<- Go Home
Inogen, Inc.
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Market Cap
$169.4M
Volume
239.0K
Cash and Equivalents
$118.9M
EBITDA
-$10.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$156.7M
Profit Margin
46.11%
52 Week High
$13.33
52 Week Low
$5.70
Dividend
N/A
Price / Book Value
0.86
Price / Earnings
-5.47
Price / Tangible Book Value
1.08
Enterprise Value
$69.7M
Enterprise Value / EBITDA
-11.86
Operating Income
-$30.9M
Return on Equity
14.10%
Return on Assets
-6.19
Cash and Short Term Investments
$118.9M
Debt
$19.2M
Equity
$198.0M
Revenue
$340.0M
Unlevered FCF
-$16.6M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium